Seroprevalence of SARS-CoV-2 in slums versus non-slums in Mumbai, India.
Anup Malani,Daksha Shah,Gagandeep Kang,Gayatri Nair Lobo,Jayanthi Shastri,Manoj Mohanan,Rajesh Jain,Sachee Agrawal,Sandeep Juneja,Sofia Imad,Ullas Kolthur-Seetharam +10 more
About:
This article is published in The Lancet Global Health.The article was published on 2021-02-01 and is currently open access. It has received 112 citations till now. The article focuses on the topics: Seroprevalence.read more
Citations
More filters
Journal ArticleDOI
Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic.
Lewis F Buss,Carlos A. Prete,Claudia M. M. Abrahim,Alfredo Mendrone,Tassila Salomon,Cesar de Almeida-Neto,Rafael F. O. França,Maria C Belotti,Maria Perpétuo Socorro Sampaio Carvalho,Allyson Guimarães Costa,Myuki A E Crispim,Suzete C. Ferreira,Nelson Abrahim Fraiji,Susie Gurzenda,Charles Whittaker,Leonardo Tadashi Kamaura,Pedro L. Takecian,Pedro S. Peixoto,Marcio K. Oikawa,Anna S. Nishiya,Vanderson Rocha,Nanci A. Salles,Andreza Aruska de Souza Santos,Martirene A da Silva,Brian Custer,Kris V Parag,Manoel Barral-Netto,Moritz U. G. Kraemer,Rafael Henrique Moraes Pereira,Oliver G. Pybus,Michael P. Busch,Marcia C. Castro,Christopher Dye,Vitor H. Nascimento,Nuno R. Faria,Nuno R. Faria,Nuno R. Faria,Ester Cerdeira Sabino +37 more
TL;DR: The spread of COVID-19 in Manaus, Brazil, shows that a largely unmitigated epidemic can infect a high fraction of the population and cause high mortality, and confirms that when poorly controlled, CO VID-19 caninfect a large proportion of the Population, causing high mortality.
Journal ArticleDOI
Serological evidence of human infection with SARS-CoV-2: a systematic review and meta-analysis.
Xinhua Chen,Zhiyuan Chen,Andrew S. Azman,Andrew S. Azman,Andrew S. Azman,Xiaowei Deng,Ruijia Sun,Zeyao Zhao,Nan Zheng,Xinghui Chen,Wanying Lu,Tingyu Zhuang,Juan Yang,Cécile Viboud,Marco Ajelli,Daniel T. Leung,Hongjie Yu +16 more
TL;DR: In this article, a systematic review and meta-analysis of serological surveys for antibodies to SARS-CoV-2 have been reported worldwide, and the authors aimed to synthesise, combine, and assess this large corpus of data.
Journal ArticleDOI
SARS-CoV-2 variant B.1.617 is resistant to bamlanivimab and evades antibodies induced by infection and vaccination.
Markus Hoffmann,Markus Hoffmann,Heike Hofmann-Winkler,Nadine Krüger,Amy Kempf,Amy Kempf,Inga Nehlmeier,Luise Graichen,Luise Graichen,Prerna Arora,Prerna Arora,Anzhalika Sidarovich,Anzhalika Sidarovich,Anna-Sophie Moldenhauer,Martin Sebastian Winkler,Sebastian R. Schulz,Hans-Martin Jäck,Metodi V. Stankov,Georg M. N. Behrens,Stefan Pöhlmann,Stefan Pöhlmann +20 more
TL;DR: In this paper, the authors analyzed whether B.1.617 is more adept in entering cells and/or evades antibody responses, and they found that antibody evasion may contribute to the rapid spread of this variant.
Journal ArticleDOI
SARS-CoV-2 antibody seroprevalence in India, August-September, 2020: findings from the second nationwide household serosurvey.
Manoj V Murhekar,Tarun Bhatnagar,Sriram Selvaraju,V. Saravanakumar,Jeromie Wesley Vivian Thangaraj,Naman Shah,Muthusamy Santhosh Kumar,Kiran Rade,R. Sabarinathan,Smita Asthana,Rakesh Balachandar,Sampada Dipak Bangar,Avi Kumar Bansal,Jyothi Bhat,Vishal Chopra,Dasarathi Das,Alok Kumar Deb,Kangjam Rekha Devi,Gaurav Raj Dwivedi,S. Muhammad Salim Khan,C. P. Girish Kumar,M. Sunil Kumar,Avula Laxmaiah,Major Madhukar,Amarendra Mahapatra,Suman Sundar Mohanty,Chethana Rangaraju,Alka Turuk,Dinesh Kumar Baradwaj,Ashrafjit S. Chahal,Falguni Debnath,Inaamul Haq,Arshad Kalliath,Srikanta Kanungo,Jaya Singh Kshatri,G G J Naga Lakshmi,Anindya Mitra,A.R. Nirmala,Ganta Venkata Prasad,Mariya Amin Qurieshi,Seema Sahay,Ramesh Kumar Sangwan,Krithikaa Sekar,Vijay K. Shukla,Prashant Singh,Pushpendra Singh,Rajeev K. Singh,Dantuluri Sheethal Varma,Ankit Viramgami,Samiran Panda,D C S Reddy,Balram Bhargava,Rushikesh Andhalkar,Anshuman Chaudhury,Hirawati Deval,Sarang Dhatrak,Rajeev Gupta,Ezhilarasan Ilayaperumal,Babu Jagjeevan,Ramesh Chandra Jha,K Kiran,Nivethitha N Krishnan,Alok Kumar,VG Vinoth Kumar,K. Nagbhushanam,Arlappa Nimmathota,Ashok Kumar Pandey,Harpreet Singh Pawar,Kushal Singh Rathore,Aby Robinson,Hari Bhan Singh,Vimith Cheruvathoor Wilson,Ashwini Yadav,Rajiv Yadav,T Karunakaran,Josephine Pradhan,T Sivakumar,Annamma Jose,K Kalaiyarasi,Sauvik Dasgupta,R Anusha,Tanu Anand,Giridhara R Babu,Himanshu Chauhan,Tanzin Dikid,Raman R. Gangakhedkar,Shashi Kant,Sanket Kulkarni,J P Muliyil,Ravindra Mohan Pandey,Swarup Sarkar,Aakash Shrivastava,Sujeet Kumar Singh,Sanjay Zodpey,Aparup Das,Pradeep Das,Shanta Dutta,Rajni Kant,Kanwar Narain,Somashekar Narasimhaiah,Sanghamitra Pati,Shripad A. Patil,Hemalatha Rajkumar,Tekumalla Ramarao,Kamalesh Sarkar,Shalini Singh,Gurudayal S Toteja,Kamran Zaman +107 more
TL;DR: A second household serosurvey among individuals aged 10 years or older in the same 700 villages or wards within 70 districts in India that were included in the first sero-survey was conducted in this article.
Journal ArticleDOI
SARS-CoV-2 seroprevalence among the general population and healthcare workers in India, December 2020-January 2021.
Manoj V Murhekar,Tarun Bhatnagar,Jeromie Wesley Vivian Thangaraj,Saravanakumar,Muthusamy Santhosh Kumar,Sriram Selvaraju,Kiran Rade,C. P. Girish Kumar,R. Sabarinathan,Alka Turuk,Smita Asthana,Rakesh Balachandar,Sampada Dipak Bangar,Avi Kumar Bansal,Vishal Chopra,Dasarathi Das,Alok Kumar Deb,Kangjam Rekha Devi,Vikas Dhikav,Gaurav Raj Dwivedi,S. Muhammad Salim Khan,M. Sunil Kumar,Avula Laxmaiah,Major Madhukar,Amarendra Mahapatra,Chethana Rangaraju,Jyotirmayee Turuk,Rajiv Yadav,Rushikesh Andhalkar,K Arunraj,Dinesh Kumar Bharadwaj,Pravin Bharti,Debdutta Bhattacharya,Jyothi Bhat,Ashrafjit S. Chahal,Debjit Chakraborty,Anshuman Chaudhury,Hirawati Deval,Sarang Dhatrak,Rakesh Dayal,D Elantamilan,Prathiksha Giridharan,Inaamul Haq,Ramesh Kumar Hudda,Babu Jagjeevan,Arshad Kalliath,Srikanta Kanungo,Nivethitha N Krishnan,Jaya Singh Kshatri,Alok Kumar +49 more
TL;DR: A third serosurvey was conducted between December 2020 and January 2021 to estimate the seroprevalence of SARS-CoV-2 infection among the general population and healthcare workers (HCWs) in India as mentioned in this paper.
References
More filters
Journal ArticleDOI
Estimating prevalence from the results of a screening test
Walter J. Rogan,Beth C. Gladen +1 more
TL;DR: A common use of tests is to estimate prevalence of disease; frequency of positive tests is shown to be a bad estimate, and the necessary adjustmants are given.
Journal ArticleDOI
A mathematical model reveals the influence of population heterogeneity on herd immunity to SARS-CoV-2.
TL;DR: By introducing age and activity heterogeneities into population models for SARS-CoV-2, herd immunity can be achieved at a population-wide infection rate of ∼40%, considerably lower than previous estimates.
Journal ArticleDOI
Performance Characteristics of the Abbott Architect SARS-CoV-2 IgG Assay and Seroprevalence in Boise, Idaho.
Andrew Bryan,Gregory Pepper,Mark H. Wener,Susan L. Fink,Chihiro Morishima,Anu Chaudhary,Keith R. Jerome,Keith R. Jerome,Patrick C. Mathias,Alexander L. Greninger,Alexander L. Greninger +10 more
TL;DR: It is expected that the availability of high-quality serological testing will be a key tool in the fight against SARS-CoV-2 as the limited circulation of the virus in the western United States.
Journal ArticleDOI
SARS-CoV-2 antibody prevalence in Brazil: results from two successive nationwide serological household surveys.
Pedro C. Hallal,Fernando Pires Hartwig,Bernardo L. Horta,Mariângela F Silveira,Claudio J. Struchiner,Luis Paulo Vidaletti,Nelson A. Neumann,Lucia Campos Pellanda,Odir Antônio Dellagostin,Marcelo Nascimento Burattini,Marcelo Nascimento Burattini,Gabriel D. Victora,Ana M. B. Menezes,Fernando C. Barros,Fernando C. Barros,Aluísio J D Barros,Cesar G. Victora +16 more
TL;DR: Antibody prevalence was highly heterogeneous by country region, with rapid initial escalation in Brazil's north and northeast, and is strongly associated with Indigenous ancestry and low socioeconomic status.
Related Papers (5)
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study.
Silvia Stringhini,Silvia Stringhini,Silvia Stringhini,Ania Wisniak,Giovanni Piumatti,Giovanni Piumatti,Andrew S. Azman,Andrew S. Azman,Stephen A. Lauer,Hélène Baysson,David De Ridder,Dusan Petrovic,Dusan Petrovic,Stephanie Schrempft,Kailing Marcus,Sabine Yerly,Isabelle Arm Vernez,Olivia Keiser,Samia Hurst,Klara M. Posfay-Barbe,Didier Trono,Didier Pittet,Laurent Getaz,Laurent Getaz,François Chappuis,François Chappuis,Isabella Eckerle,Isabella Eckerle,Nicolas Vuilleumier,Nicolas Vuilleumier,Benjamin Meyer,Antoine Flahault,Antoine Flahault,Laurent Kaiser,Laurent Kaiser,Idris Guessous,Idris Guessous +36 more
Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study.
Marina Pollán,Beatriz Pérez-Gómez,Roberto Pastor-Barriuso,Jesús Oteo,Miguel A. Hernán,Miguel A. Hernán,Mayte Pérez-Olmeda,Jose L Sanmartín,Aurora Fernández-García,Aurora Fernández-García,Israel Cruz,Nerea Fernández de Larrea,Marta Molina,Francisco Rodríguez-Cabrera,Mariano Martín,Paloma Merino-Amador,Jose León Paniagua,Juan F Muñoz-Montalvo,Faustino Blanco,Raquel Yotti,Rodrigo Gutiérrez Fernández,Saturnino Mezcua Navarro,Matías Salinero Hernández,Manuel Cuenca-Estrella,Pablo Fernández-Navarro,Ana Avellón,Giovanni Fedele,Jesús Oteo Iglesias,María Teresa Pérez Olmeda,Maria Elena Martinez,Francisco D. Rodríguez-Cabrera,Susana Padrones Fernández,José Manuel Rumbao Aguirre,José M. Navarro Marí,Begoña Palop Borrás,Ana Belén Pérez Jiménez,Manuel Rodríguez-Iglesias,Ana María Calvo Gascón,María Luz Lou Alcaine,Ignacio Donate Suárez,Oscar Suárez Álvarez,Mercedes Rodríguez Pérez,Margarita Cases Sanchís,Carlos Javier Villafáfila Gomila,Lluis Carbo Saladrigas,Adoración Hurtado Fernández,Antonio Oliver,Elías Castro Feliciano,María Noemí González Quintana,José María Barrasa Fernández,María Araceli Hernández Betancor,Melisa Hernández Febles,Leopoldo Martín Martín,Luis-Mariano López López,Teresa Ugarte Miota,Inés De Benito Población,María Sagrario Celada Pérez,María Natalia Vallés Fernández,Tomás Maté Enríquez,Miguel Villa Arranz,Marta Domínguez-Gil González,Isabel Fernández-Natal,Gregoria Megías Lobón,Juan Luis Muñoz Bellido,Pilar Ciruela,Ariadna Mas i Casals,Maria Doladé Botías,M. Angeles Marcos Maeso,Dúnia Pérez del Campo,Antonio Félix de Castro,Ramón Limón Ramírez,Maria Francisca Elías Retamosa,Manuela Rubio González,María Sinda Blanco Lobeiras,Alberto Fuentes Losada,Antonio Aguilera,Germán Bou,Yolanda Caro,Noemí Marauri,Luis Miguel Soria Blanco,Isabel González,Montserrat Hernández Pascual,Roberto Alonso Fernández,Natalia Cabrera Castro,Aurora Tomás Lizcano,Cristóbal Ramírez Almagro,M. Hernández,Nieves Ascunce Elizaga,María Ederra Sanz,Carmen Ezpeleta Baquedano,Ana Bustinduy Bascaran,Susana Iglesias Tamayo,Luis Elorduy Otazua,Rebeca Benarroch Benarroch,Jesús Lopera Flores,Antonia Vázquez de la Villa +95 more
SARS-CoV-2 antibody prevalence in Brazil: results from two successive nationwide serological household surveys.
Pedro C. Hallal,Fernando Pires Hartwig,Bernardo L. Horta,Mariângela F Silveira,Claudio J. Struchiner,Luis Paulo Vidaletti,Nelson A. Neumann,Lucia Campos Pellanda,Odir Antônio Dellagostin,Marcelo Nascimento Burattini,Marcelo Nascimento Burattini,Gabriel D. Victora,Ana M. B. Menezes,Fernando C. Barros,Fernando C. Barros,Aluísio J D Barros,Cesar G. Victora +16 more